Genmab
GMAB
GMAB
219 hedge funds and large institutions have $1.23B invested in Genmab in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 93 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
219
Holders Change
-7
Holders Change %
-3.1%
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
69
Reduced
93
Closed
33
Calls
$178K
Puts
$696K
Net Calls
-$518K
Net Calls Change
-$134K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$31.9M |
| 2 |
Two Sigma Investments
New York
|
$17.8M |
| 3 |
DP
DDD Partners
Bellevue,
Washington
|
$8.86M |
| 4 |
Two Sigma Advisers
New York
|
$8.4M |
| 5 |
Goldman Sachs
New York
|
$22.1M |
